Alytix is a pioneering biotechnology brand that is revolutionizing the fight against bacterial infections. With the misuse and overuse of antimicrobials causing a global crisis, Alytix offers innovative and efficient solutions to combat this silent pandemic. In 2019 alone, antibiotic-resistant infections claimed the lives of over 5 million people worldwide, surpassing previous estimates and equating to the populations of major cities like Los Angeles and Paris.

Alytix addresses this pressing issue by developing specific, safe, and sustainable alternatives using genomic and bioinformatic tools. Their focus is on the agricultural and human health sectors, offering bacteriophage-based solutions for the treatment and prevention of infectious diseases, including antibiotic-resistant strains. Bacteriophages are viruses that specifically target and kill bacteria, making them harmless to other living organisms.

Through their innovative products, Alytix supports the improvement of animal and human health. They develop solutions tailored to the needs and threats in the poultry, swine, and bovine industries, providing preventive and treatment options for bacterial infections. With over 10 years of experience collaborating with research groups and companies, Alytix has become a trusted leader in the field.

Contact Alytix today to join them in mitigating the impact of antimicrobial resistance